Using the Maximum Test Statistic in the Two-Period Crossover Clinical Trial

DOI10.2307/2531908MaRDI QIDQ3489334zbMATH OpenOpenAlexWikidataFDO

Authors Andrew R. Willan

Publication date 1988

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2307/2531908

zbMATH Keywords

carryovercrossover trialmaximum test statisticpowerprecision

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Use of Two-Stage Test Statistic in the Two-Period Crossover Trials
• The performance of a two-stage analysis of ABAB/BABA crossover trials
• Interim Analyses in 2 x 2 Crossover Trials
• Nonparametric analysis of the two-period two-treatment crossover design
• Nonparametric Methods in Crossover Trials

Cited in

(6)

• An exact Cochran--Armitage test for trend when dose--response shapes are a priori unknown.
• The performance of a two-stage analysis of ABAB/BABA crossover trials
• Repeated measurements designs - a review
• Interim Analyses in 2 x 2 Crossover Trials
• Use of Two-Stage Test Statistic in the Two-Period Crossover Trials
• An objective Bayesian analysis of a crossover design via model selection and model averaging

This page was built for publication: Using the Maximum Test Statistic in the Two-Period Crossover Clinical Trial

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3489334)